Bionovis and Merck KGaA sign agreement to produce eight biosimilars
Brazilian biotech company Bionovis and Germany’s Merck KGaA (MRK: DE) have signed an agreement for the development and production of biological medicines in Brazil, according to Brazil Pharma News.